栏目: 综　述

摘要
• 摘要: 应激反应是机体应对环境变化的一种适应模式。适度应激反应可诱导机体建立有效的适应策略以提高生存能力，而过度的应激反应会引起机体应激损伤，导致多种生理或心理相关疾病的发生发展，其中也包括糖尿病。糖尿病是一种典型的应激相关疾病，已有大量证据表明糖尿病的发生发展过程与代谢应激、氧化应激和内质网应激密切相关，然而各种应激反应调控糖尿病的具体分子机制及如何通过调变应激反应来预防和治疗糖尿病仍有待进一步研究。本文对应激反应的概念、调控机制及各种应激反应在糖尿病发病过程中的功能和作用机制进行概述，重点关注近年来应激医学在糖尿病研究领域的前沿发展，以期为糖尿病的预防与治疗提供理论依据和参考。未来的研究应重点阐明介导应激反应调控糖尿病发病过程的关键因子作为药物靶标的临床应用价值，并加速推进相关的转化医学研究。

  关键词:
  • 应激 / 
  • 应激反应 / 
  • 应激调控机制 / 
  • 应激医学 / 
  • 糖尿病 
  Abstract: Stress response is an adaptive process of the organism to confront environmental perturbation. Moderate stress response induces the organism to establish effective adaptive strategies for survival, while excessive stress response results in stress injury, which is a major cause of a variety of physical or psychological diseases, including diabetes mellitus. Diabetes mellitus is a typical stress-related disease, with numerous evidence indicating that the development and progression of diabetes mellitus are closely related to stress response, such as metabolic stress, oxidative stress and endoplasmic reticulum stress. However, the detailed mechanisms of stress response mediated regulation of diabetes mellitus and how to prevent or treat diabetes mellitus via modification of stress response remain to be further investigated. Here, we will introduce the definition and regulatory mechanisms of stress response, as well as discuss the biological functions and mechanisms of various stress responses during the pathogenesis of diabetes mellitus. This review highlights recent advances of stress medicine associated with diabetes mellitus, in order to provide theoretical basis and reference for prevention and treatment of diabetes mellitus. Future studies should focus on elucidating the clinical application potential of the key factors of stress response that mediate the pathogenesis of diabetes mellitus, as well as boosting the related translational medicine studies.

  Key words:
  • Stress / 
  • Stress response / 
  • Stress regulatory mechanism / 
  • Stress medicine / 
  • Diabetes mellitus 
HTML全文
参考文献(49)

• [1]	RUSSELL G, LIGHTMAN S. The human stress response. Nat Rev Endocrinol,2019,15(9): 525–534. doi: 10.1038/s41574-019-0228-0
  [2]	FAN W. Epidemiology in diabetes mellitus and cardiovascular disease. Cardiovasc Endocrinol,2017,6(1): 8–16. doi: 10.1097/XCE.0000000000000116
  [3]	American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care,2014,37(Suppl 1): S81–S90.
  [4]	SZABLEWSKI L. Glucose transporters in healthy heart and in cardiac disease. Int J Cardiol,2017,230: 70–75. doi: 10.1016/j.ijcard.2016.12.083
  [5]	ZHANG Y, SOWERS J R, REN J. Targeting autophagy in obesity: from pathophysiology to management. Nat Rev Endocrinol,2018,14(6): 356–376. doi: 10.1038/s41574-018-0009-1
  [6]	WELLEN K E, THOMPSON C B. Cellular metabolic stress: considering how cells respond to nutrient excess. Mol Cell,2010,40(2): 323–332. doi: 10.1016/j.molcel.2010.10.004
  [7]	WANG Y, HU H, YIN J, et al. TLR4 participates in sympathetic hyperactivity post-MI in the PVN by regulating NF-κB pathway and ROS production. Redox Biol, 2019, 24: 101186[2020-12-28]. https://doi.org/10.1016/j.redox.2019.101186.
  [8]	LIN L, CAO L, LIU Y, et al. B7-H3 promotes multiple myeloma cell survival and proliferation by ROS-dependent activation of Src/STAT3 and c-Cbl-mediated degradation of SOCS3. Leukemia,2019,33(6): 1475–1486. doi: 10.1038/s41375-018-0331-6
  [9]	ZHANG Y, QU Y, LIN Y, et al. Enoyl-CoA hydratase-1 regulates mTOR signaling and apoptosis by sensing nutrients. Nat Commun, 2017, 8(1): 464[2020-12-28]. https://www.nature.com/articles/s41467-017-00489-5. doi: 10.1038/s41467-017-00489-5.
  [10]	WANG T, CAO Y, ZHENG Q, et al. SENP1-SIRT3 signaling controls mitochondrial protein acetylation and metabolism. Mol Cell,2019,75(4): 823–834. doi: 10.1016/j.molcel.2019.06.008
  [11]	CHIO I I C, TUVESON D A. ROS in cancer: the burning question. Trends Mol Med,2017,23(5): 411–429. doi: 10.1016/j.molmed.2017.03.004
  [12]	HAYES J D, DINKOVA-KOSTOVA A T, TEW K D. Oxidative stress in cancer. Cancer Cell,2020,38(2): 167–197. doi: 10.1016/j.ccell.2020.06.001
  [13]	SCHMIDLIN C J, DODSON M B, MADHAVAN L, et al. Redox regulation by NRF2 in aging and disease. Free Radic Biol Med,2019,134: 702–707. doi: 10.1016/j.freeradbiomed.2019.01.016
  [14]	KLOTZ L O, STEINBRENNER H. Cellular adaptation to xenobiotics: interplay between xenosensors, reactive oxygen species and FOXO transcription factors. Redox Biol,2017,13: 646–654. doi: 10.1016/j.redox.2017.07.015
  [15]	SONG M, CUBILLOS-RUIZ J R. Endoplasmic reticulum stress responses in intratumoral immune cells: implications for cancer immunotherapy. Trends Immunol,2019,40(2): 128–141. doi: 10.1016/j.it.2018.12.001
  [16]	FRAKES A E, DILLIN A. The UPRER: sensor and coordinator of organismal homeostasis. Mol Cell,2017,66(6): 761–771. doi: 10.1016/j.molcel.2017.05.031
  [17]	CAKIR I, NILLNI E A. Endoplasmic reticulum stress, the hypothalamus, and energy balance. Trends Endocrinol Metab,2019,30(3): 163–176. doi: 10.1016/j.tem.2019.01.002
  [18]	WANG M, KAUFMAN R J. Protein misfolding in the endoplasmic reticulum as a conduit to human disease. Nature,2016,529(7586): 326–335. doi: 10.1038/nature17041
  [19]	RUEGSEGGER G N, CREO A L, CORTES T M, et al. Altered mitochondrial function in insulin-deficient and insulin-resistant states. J Clin Invest,2018,128(9): 3671–3681. doi: 10.1172/JCI120843
  [20]	HOTAMISLIGIL G S. Inflammation, metaflammation and immunometabolic disorders. Nature,2017,542(7640): 177–185. doi: 10.1038/nature21363
  [21]	CHOUCHANI E T, KAZAK L, JEDRYCHOWSKI M P, et al. Mitochondrial ROS regulate thermogenic energy expenditure and sulfenylation of UCP1. Nature,2016,532(7597): 112–116. doi: 10.1038/nature17399
  [22]	FAKHRUDDIN S, ALANAZI W, JACKSON K E. Diabetes-induced reactive oxygen species: mechanism of their generation and role in renal injury. J Diabetes Res, 2017, 2017: 8379327[2020-12-28]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5253173/. doi: 10.1155/2017/8379327.
  [23]	NOLAN C J, RUDERMAN N B, KAHN S E, et al. Insulin resistance as a physiological defense against metabolic stress: implications for the management of subsets of type 2 diabetes. Diabetes,2015,64(3): 673–686. doi: 10.2337/db14-0694
  [24]	USSHER J R, CAMPBELL J E, MULVIHILL E E, et al. Inactivation of the glucose-dependent insulinotropic polypeptide receptor improves outcomes following experimental myocardial infarction. Cell Metab,2018,27(2): 450–460. doi: 10.1016/j.cmet.2017.11.003
  [25]	JAIS A, SOLAS M, BACKES H, et al. Myeloid-cell-derived VEGF maintains brain glucose uptake and limits cognitive impairment in obesity. Cell,2016,165(4): 882–895. doi: 10.1016/j.cell.2016.03.033
  [26]	KENNY H C, ABEL E D. Heart failure in type 2 diabetes mellitus. Circ Res,2019,124(1): 121–141. doi: 10.1161/CIRCRESAHA.118.311371
  [27]	LEVASSEUR E M, YAMADA K, PIÑEROS A R, et al. Hypusine biosynthesis in β cells links polyamine metabolism to facultative cellular proliferation to maintain glucose homeostasis. Sci Signal, 2019, 12(610): eaax0715[2020-12-28]. https://stke.sciencemag.org/content/12/610/eaax0715.long. doi: 10.1126/scisignal.aax0715.
  [28]	WEIR G C. Glucolipotoxicity, β-cells, and diabetes: the emperor has no clothes. Diabetes,2020,69(3): 273–278. doi: 10.2337/db19-0138
  [29]	GERBER P A, RUTTER G A. The role of oxidative stress and hypoxia in pancreatic beta-cell dysfunction in diabetes mellitus. Antioxid Redox Signal,2017,26(10): 501–518. doi: 10.1089/ars.2016.6755
  [30]	LEE Y S, WOLLAM J, OLEFSKY J M. An integrated view of immunometabolism. Cell,2018,172(1/2): 22–40. doi: 10.1016/j.cell.2017.12.025
  [31]	KLEINER S, GOMEZ D, MEGRA B, et al. Mice harboring the human SLC30A8 R138X loss-of-function mutation have increased insulin secretory capacity. Proc Natl Acad Sci U S A,2018,115(32): E7642–E7649. doi: 10.1073/pnas.1721418115
  [32]	POCIOT F, LERNMARK Å. Genetic risk factors for type 1 diabetes. Lancet,2016,387(10035): 2331–2339. doi: 10.1016/S0140-6736(16)30582-7
  [33]	CATRYSSE L, VAN LOO G. Inflammation and the metabolic syndrome: the tissue-specific functions of NF-κB. Trends Cell Biol,2017,27(6): 417–429. doi: 10.1016/j.tcb.2017.01.006
  [34]	KITADA M, OGURA Y, MONNO I, et al. Sirtuins and type 2 diabetes: role in inflammation, oxidative stress, and mitochondrial function. Front Endocrinol, 2019, 10: 187[2020-12-28]. https://doi.org/10.3389/fendo.2019.00187.
  [35]	STUART C A, HOWELL M E, CARTWRIGHT B M, et al. Insulin resistance and muscle insulin receptor substrate‐1 serine hyperphosphorylation. Physiol Rev, 2014, 2(12): e12236[2020-12-28]. https://doi.org/10.14814/phy2.12236.
  [36]	PETERSEN M C, SHULMAN G I. Mechanisms of insulin action and insulin resistance. Physiol Rev,2018,98(4): 2133–2223. doi: 10.1152/physrev.00063.2017
  [37]	YANG J D, HAINAUT P, GORES G J, et al. A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat Rev Gastroenterol Hepatol,2019,16(10): 589–604. doi: 10.1038/s41575-019-0186-y
  [38]	KAHN C R, WANG G, LEE K Y. Altered adipose tissue and adipocyte function in the pathogenesis of metabolic syndrome. J Clin Invest,2019,129(10): 3990–4000. doi: 10.1172/JCI129187
  [39]	REILLY S M, SALTIEL A R. Adapting to obesity with adipose tissue inflammation. Nat Rev Endocrinol,2017,13(11): 633–643. doi: 10.1038/nrendo.2017.90
  [40]	ZHANG Y, KIM M S, JIA B, et al. Hypothalamic stem cells control ageing speed partly through exosomal miRNAs. Nature,2017,548(7665): 52–57. doi: 10.1038/nature23282
  [41]	SONG M, SANDOVAL T A, CHAE C S, et al. IRE1α–XBP1 controls T cell function in ovarian cancer by regulating mitochondrial activity. Nature,2018,562(7727): 423–428. doi: 10.1038/s41586-018-0597-x
  [42]	OLZMANN J A, CARVALHO P. Dynamics and functions of lipid droplets. Nat Rev Mol Cell Biol,2019,20(3): 137–155. doi: 10.1038/s41580-018-0085-z
  [43]	CUBILLOS-RUIZ J R, BETTIGOLE S E, GLIMCHER L H. Tumorigenic and immunosuppressive effects of endoplasmic reticulum stress in cancer. Cell,2017,168(4): 692–706. doi: 10.1016/j.cell.2016.12.004
  [44]	HETZ C, PAPA F R. The unfolded protein response and cell fate control. Mol Cell,2018,69(2): 169–181. doi: 10.1016/j.molcel.2017.06.017
  [45]	LEBEAUPIN C, VALLÉE D, HAZARI Y, et al. Endoplasmic reticulum stress signalling and the pathogenesis of non-alcoholic fatty liver disease. J Hepatol,2018,69(4): 927–947. doi: 10.1016/j.jhep.2018.06.008
  [46]	CHEN S, HENDERSON A, PETRIELLO M C, et al. Trimethylamine N-oxide binds and activates PERK to promote metabolic dysfunction. Cell Metab, 2019, 30(6): 1141-1151. e5[2020-12-28]. https://doi.org/10.1016/j.cmet.2019.08.021.
  [47]	MEEX R C R, WATT M J. Hepatokines: linking nonalcoholic fatty liver disease and insulin resistance. Nat Rev Endocrinol,2017,13(9): 509–520. doi: 10.1038/nrendo.2017.56
  [48]	LI W, ZHU J, DOU J, et al. Phosphorylation of LAMP2A by p38 MAPK couples ER stress to chaperone-mediated autophagy. Nat Commun,2017,8(1): 1–14. doi: 10.1038/s41467-016-0009-6
  [49]	FUMAGALLI F, NOACK J, BERGMANN T J, et al. Translocon component Sec62 acts in endoplasmic reticulum turnover during stress recovery. Nat Cell Biol,2016,18(11): 1173–1184. doi: 10.1038/ncb3423

相关文章
施引文献
资源附件(0)
访问统计
•